$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Which manufacturer produces niraparibabiraterone tablets?
2026-02-01 22:25:32
Check Details
Enantuzumab’s estimated selling price in 2025
2026-02-01 22:25:32
Check Details
How long does a course of tocilizumab take?
2026-02-01 22:25:32
Check Details
What are the main therapeutic effects of Etrasimod?
2026-02-01 22:25:32
Check Details
What is the weight loss effect after using Zilucoplan?
2026-02-01 22:25:32
Check Details
Rozelixizumab injection price comparison
2026-02-01 22:25:32
Check Details
Are niraparib and abiraterone tablets really targeted drugs?
2026-02-01 22:25:32
Check Details
Precautions during use of enantuzumab
2026-02-01 22:25:32
Check Details
What are the main indications for tocilizumab?
2026-02-01 22:25:32
Check Details
Itramod can be safely used with opioids, antidepressants in ulcerative colitis
2026-02-01 22:25:32
Check Details
How should Zilucoplan be used?
2026-02-01 22:25:32
Check Details
What are the advantages of tucatinib in terms of efficacy and side effects?
2026-02-01 22:25:32
Check Details
1
2
...
1835
1836
1837
1838
1839
1840
1841
...
10227
10228
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Long-Term Anagrelide Use: Common Adverse Effects and Key Monitoring Considerations
2
Resmetirom Indication Clarification: Approved for NASH Fibrosis, Not Hepatitis B Cirrhosis
3
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy
4
Anagrelide vs. Hydroxyurea in Essential Thrombocythemia: Efficacy Profiles and Clinical Positioning
5
SCEMBLIX (Asciminib) Side Effect Management & Special Population Guide
6
Sabril (Vigabatrin) Explained: Indications, Vision Loss Risk & Key Warnings
7
FDA Approves Tauklarify for Tau PET Imaging in Alzheimer's Disease Assessment
8
First CELMoD Drug Zenbexus Wins FDA Accelerated Approval for Multiple Myeloma
9
Elamipretide Side Effects and Medication Safety Guide: Injection Site Reactions and Storage Essentials
10
Dutasteride Soft Capsules: Comprehensive Side Effect Profile and Management Strategies
11
Oral Semaglutide Tablets: A Complete Guide to the GLP-1 Receptor Agonist for Type 2 Diabetes and Cardiovascular Protection
12
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor